Log in

CNSX:MJTrue Leaf Medicine International Stock Price, Forecast & News

$0.04
-0.01 (-18.18 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.05
Now: $0.05
$0.05
50-Day Range
$0.03
MA: $0.04
$0.07
52-Week Range
$0.16
Now: $0.05
$1.52
Volume223,971 shs
Average Volume67,721 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
True Leaf Medicine International Ltd. manufactures and distributes hemp-based nutrition for pets. As of October 24, 2018, it sold dog chews, dental sticks, and supplement oils under the True Hemp name in approximately 2,000 stores worldwide, including PetSmart Canada and Pets Corner UK, as well as through online on Amazon. The company was founded in 2013 and is headquartered in Vernon, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-778-4755323

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees13
Next Earnings DateN/A
OptionableOptionable

Receive MJ News and Ratings via Email

Sign-up to receive the latest news and ratings for MJ and its competitors with MarketBeat's FREE daily newsletter.

True Leaf Medicine International (CNSX:MJ) Frequently Asked Questions

Has True Leaf Medicine International been receiving favorable news coverage?

Media stories about MJ stock have been trending extremely negative this week, InfoTrie Sentiment reports. The research firm identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. True Leaf Medicine International earned a news impact score of -4.0 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the next few days. View the latest news aboutTrue Leaf Medicine International.

Who are some of True Leaf Medicine International's key competitors?

What other stocks do shareholders of True Leaf Medicine International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other True Leaf Medicine International investors own include Alliance Growers (ACG), OrganiGram (OGI), Proteostasis Therapeutics (PTI), Canopy Growth (CGC), CannTrust (CNTTF), Cronos Group (CRON), Curaleaf (CURLF), Idera Pharmaceuticals (IDRA), Insys Therapeutics (INSY) and Journey Energy (JOY).

Who are True Leaf Medicine International's key executives?

True Leaf Medicine International's management team includes the following people:
  • Mr. Darcy E. Bomford, Founder, Pres, CEO & Director (Age 53)
  • Mr. Charles Tait Austin, Advisor (Age 82)
  • Mr. Kerry David Biggs CPA, CGA, MBA, Chief Financial Officer
  • Bal Bhullar, Gen. Counsel
  • Mr. Paul Sullivan, Director of PR

What is True Leaf Medicine International's stock symbol?

True Leaf Medicine International trades on the CNSX under the ticker symbol "MJ."

How do I buy shares of True Leaf Medicine International?

Shares of MJ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is True Leaf Medicine International's stock price today?

One share of MJ stock can currently be purchased for approximately $0.05.

What is True Leaf Medicine International's official website?

The official website for True Leaf Medicine International is www.trueleaf.com.

How can I contact True Leaf Medicine International?

True Leaf Medicine International's mailing address is 100 Kalamalka Lake Rd Unit 32, VERNON, BC V1T 9G1, Canada. The company can be reached via phone at +1-778-4755323.

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.